Patent Trouble | GenomeWeb

Patent Trouble

Genentech has accused the University of Pennsylvania of committing "patent fraud," reports The Daily Pennsylvanian's Laura Cofsky. The company is suing the school over a cancer treatment they both say is theirs, Cofsky says. Penn tested the treatment on transgenic mice engineered to develop cancer, and accused Genentech of patent infringement when the school noticed a patent from the company for the same treatment.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

In Nucleic Acids Research this week: transcriptome patterns of Zika-infected cells, updated Comparative Toxicogenomics Database, and more.

BMJ study says that about half of former hematology-oncology regulators now work for industry.

Science should wish PhDs who leave academia well, a Nature editorial says.

New York-based doctors announce the birth of a baby boy whose parents underwent mitochondrial transfer therapy, New Scientist reports.